Severity of lethal ischemia/reperfusion injury in rat hearts subjected to ischemic preconditioning is increased under conditions of simulated hyperglycemia

Physiological Research

Volumn 63, Issue 5, 2014, Pages 577-585

  Zalesak M ^a   Blazicek P ^b   Pancza, D ^a   Ledvenyiova V ^a   Bartekova M ^a   Nemcekova M ^a   Carnicka S ^a   Ziegelhoffer A ^a   Ravingerova T ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b Laboratory of Clinical Biochemistry and Hematology Alpha Medical   (Slovakia)

Author keywords

Acute myocardial infarction; h FABP; Ischemia reperfusion injury; Ischemic preconditioning; Simulated hyperglycemia

Indexed keywords

FABP3 PROTEIN, RAT; FATTY ACID BINDING PROTEIN; GLUCOSE;

ANIMAL; COMPLICATION; DISEASE MODEL; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART VENTRICLE PRESSURE; HYPERGLYCEMIA; MALE; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; TIME; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY ACID-BINDING PROTEINS; GLUCOSE; HYPERGLYCEMIA; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS, WISTAR; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 84920030114     PISSN: 08628408     EISSN: 18029973     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. ALHADI HA, FOX KA: Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acidbinding protein. QJM 97: 187-198, 2004.
2. BALAKUMAR RP, SHARMA NK: Healing the diabetic heart: does myocardial preconditioning work?. Cell Signal 24: 53-59, 2012.
3. BEHAR S, REICHERREISS H, ABINADER E: The prognostic significance of angina pectoris precede the occurence of a first acute infarction in 4166 consecutive hospitalized patients. Am Heart J 12: 1481-1486, 1992.
4. CAI L, LI W, WANG G, GUO L, JIANG Y, KANG YJ: Hyperglycemia-induced apoptosis in mouse myocardium:mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes 51: 1938-1948, 2002.
5. CHAN CP, SANDERSON JE, GLATZ JF, CHENG WS, HEMPEL A, RENNEBERG R: A superior early myocardial infarction marker. Human heart-type fatty acid binding protein. Z Kardiol 93: 388-397, 2004.
6. CHEN H, SHEN WL, WANG XH, CHEN HZ, GU JZ, FU J, NI YF, GAO PJ, ZHU DL, HIGASHINO H: Paradoxically enhanced heart tolerance to ischemia in type 1 diabetes and role of increased osmolarity. Clin Exp Pharmacol Physiol 33: 910-916, 2006.
7. CLODFELDER-MILLER B, DE SARNO P, ZMIJEWSKA AA, SONG L, JOPE RS: Physiological and Pathological Changes in Glucose Regulate Brain Akt and Glycogen Synthase Kinase-3*. J Biol Chem 280: 39723-39731, 2005.
8. FEUVRAY D, LOPASCHUK GD: Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res 34: 113-120, 1997.
9. FIORDALISO F, LERI A, CESSELI D, LIMANA F, SAFAI B, NADAL-GINARD B, ANVERSA P, KAJSTURA J: Hyperglycemia activates p53 regulated genes leading to myocyte cell death. Diabetes 50: 2363-2375, 2001.
10. IGLEWICZ B, HOAGLIN D: How to detect and handle outliers. In: ASQC Basic References in Quality Control:Statistical Techniques. MYKYTKA EF (ed), ASCQ Quality Press, Milwaukee, 1993.
11. ISHIHARA M, INOUE I, KAWAGOE T, SHIMATANI Y, KURISU S, NISHIOKA K, KOUNO Y, UMEMURA T, NAKAMURA S, SATO H: Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 38: 1007-1011, 2001.
12. JIA YZ, SATO S: Evaluation of coronary collateral circulation in early ischemia in rat hearts. A morphological study. Nihon Ika Daikagu Zasshi 64: 329-336, 1997.
13. KARMAZYN M: The myocardial sodium-hydrogen exchanger (NHE) and its role in mediating ischemic and reperfusion injury. Keio J Med 47: 65-72, 1995.
14. KERSTEN JR, SCHMELING TJ, ORTH KG, PAGEL PS, WARLTIER DC: acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol 275: H721-H725-1998, .
15. KIM HS, KIM SY, KWAK YL, HWANG KC, SHIM YH: Hyperglycemia attenuates myocardial preconditioning of remifentanil. J Surg Res 174: 231-237, 2012.
16. KLEINE AH, GLATZ JF, VAN NIEWENHOVEN FA: Release of heart fatty acid binding protein into plasma after AMI in man. Mol Cell Biochem 116: 155-162, 1992.
17. KLONER RA, SHOOK T, PRZYKLENK K, DAVIS VG, JUNIO L, MATTHEWS RV, BURSTEIN S, GIBSON M, POOLE WK, CANNON CP, ET AL.: Previous angina alters in-hospital outcome in TIMI-4. A clinical correlate to preconditioning?. Circulation 91: 37-45, 1995.
18. KLONER RA, SHOOK T, ANTMAN EM, CANNON CP, PRZYKLENK K, YOO K, MCCABE CH, BRAUNWALD E: Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation 97: 1042-1045, 1998.
19. KORTHIUS RJ, GUTE DC, CEPINSKAS G, KVIETYS PR: Celular mechanisms of acute versus delayed preconditioning. Pathophysiology 5: 35-48, 1998.
20. LI Y, LI Y, FENG Q, ARNOLD M, PENG T: Calpain activation contributes to hyperglycemia-induced apoptosis in cardiomyocytes. Cardiovasc Res 84: 100-110, 2009.
21. LIU Y, THORNTON JD, COHEN MV, DOVNEY JM, SCHAFFER SW: Streptozotocin-induced non-insulindependent diabetes protects the heart from infarction. Circulation 88: 1273-1278, 1993.
22. MIURA T, NISHIHARA M, MIKI T: Drug developement targeting the glycogen synthase kinase-3beta (GSK-3beta)- mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury. J Pharmacol Sci 109: 162-167, 2009.
23. MONITORI-GRAU M, OSORIO-CONLES O, OROZCO A, SERRANO-MARCO L, VÁZQUES-CARRERA M, GÓMEZ-FOIX AM: Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes. Cell Signal 25: 1318-1327, 2013.
24. MURRY CE, JENNINGS RB, REIMER KA: New insights into potential mechanism of preconditioning. Circulation 84: 442-445, 1991.
25. NAKAGAWA Y, ITO H, KITAKAZE M, KUSUOKA H, HORI M, KUZUYA T, HIGASHINO Y, FUJII K, MINAMINO T: Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of "preconditioning". J Am Coll Cardiol 25: 1076-1083, 1995.
26. NIZAMUTDINOVA IT, GULERIA RS, SINGH AB, KENDAL JA, BAKER KM, PAN J: Retinoid acid protects cardiomyocytes from high glucose-induced apoptosis through inhibition of NF-κB signaling pathway. J Cell Physiol 228: 380-392, 2013.
27. PRABHAKAR SS: Tetrahydrobiopterin reverses the inhibition of nitric oxide by high glucose in cultured murine mesangial cells. Am J Physiol 281: F179-F188-2001, .
28. RAJAMANI U, JOSEPH D, ROUX S, ESSOP MF: The hexosamine biosynthetic pathway can mediate myocardial apoptosis in a rat model of diet-induced insuline resistance. Acta Physiol (Oxf) 202: 151-157, 2011.
29. RAVINGEROVÁ T, ŠTETKA R, PANCZA D, ULIČNÁ O, ZIEGELHÖFFER A, STYK J: Susceptibility to ischemiainduced arrhytmias and the effect of preconditioning in the diabetic rat heart. Physiol Res 49: 607-616, 2000.
30. RAVINGEROVÁ T, NECKÁŘ J, KOLÁŘ F: Ischemic tolerance of rat hearts in acute and chronic phase of experimental diabetes. Mol Cell Biochem 249: 167-174, 2003.
31. RAVINGEROVÁ T, MATEJÍKOVÁ J, ADAMEOVÁ A, NEMČEKOVÁ M, PECHAŇOVÁ O, KELLY T, SUMBALOVÁ Z, LAZOU A: Adaptive mechanism in the diabetic myocardium: an alternative form of endogenous cardioproítection and its loss. In: Adaptation Biology and Medicine. P WANG, CH KUO, N TAKEDA, PK SINGAL (eds), Narosa Publishing House, New Delhi, 2011, pp 59-75.
32. RICCI C, JONG CJ, SCHAFFER SW: Proapoptotic and antiapoptotic effects of hyperglycemia: role of insulin signaling. Can J Physiol 86: 166-172, 2008.
33. SCHAFFER SW, CROFT CB, SOLODUSHKO V: Cardioprotective effect of chronic hyperglycemia: effect on hypoxia-induced apoptosis and necrosis. Am J Physiol 278: H1948-H1954-2000, .
34. SCHULZ R, COHEN MV, BEHRENDS M, DOWNEY JM, HEUSCH G: Signal transduction of ischemic preconditioning. Cardiovasc Res 52: 181-198, 2001.
35. SHIZUKUDA Y, REYLAND ME, BUTTRICK PM: Protein kinase C-delta modulates apoptosis induced by hyperglycemia in adult ventricular myocytes. Am J Physiol 282: H1625-H1634-2002, .
36. SINGH AB, GULERIA RS, NIZAMUDTINOVA IT, BAKER KM, PAN J: High glucose-induced represion of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling. J Cell Physiol 227: 2632-2644, 2012.
37. SOBEL BE, BRESNAHAN GF, SHELL WE, YODER RD: Estimation of infarct size in man and its relation to prognosis. Circulation 46: 640-648, 1972.
38. SOHMIYA K, TANAKA T, TSUJI R, YOSHIMOTO K, NAKAYAMA Y, HIROTA Y, KAWAMURA K, MATSUNAGA Y, NISHIMURA S, MIYAZAKI H: Plasma and urinary heart-type cytoplasmatic fatty acidbinding protein in coronary occlusion and reperfusion induced myocardial injury model. J Mol Cell Cardiol 25: 1413-1426, 1993.
39. ŠVORC P, ŠEFARA P, BARČOKOVÁ I: Ischaemic preconditioning - laboratory curiosity or endogenous protection of myocardium before ischaemia? (in Slovak). Cardiol 12: 21-27, 2003.
40. TANI M, NEELY J: Hearts from diabetic rats are more resistant to in vitro ischemia: possible role of altered Ca2+ metabolism. Circ Res 62: 931-940, 1988.
41. TOSAKI A, ENGELMAN DT, ENGELMAN RM, DAS DK: The evolution of diabetic response to ischemia/reperfusion and preconditioning in isolated working rat hearts. Cardiovasc Res 31: 526-536, 1996.
42. TSANG A, HAUSENLOY DJ, MOCANU MM, CARR RD, YELLON DM: Preconditioning the diabetic heart. The importance of Akt phosphorylation. Diabetes 54: 2360-2364, 2005.
43. TSUJI R, TANAKA T, SOHMIYA K, HIROTA Y, YOSHIMOTO K, KINOSHITA K, KUSAKA Y, KAWAMURA K, MORITA H, ABE S: Human heart-type cytoplasmatic fatty acid binding protein in serum and urine during hyperacute myocardial infarction. Int J Cardiol 41: 209-217, 1993.
44. VEERKAMP JH, VAN MOERKERK HTB, PRINSEN CFM, VAN KUPPEVELT TH: Structural and functional studies on different human FABP types. Mol Cell Biochem 192: 137-142, 1999.
45. VLADIC N, GE ZG, LEUCKER T, BRZEZINSKA AK, DU JH, SHI Y, WARLTIER DC, PRATT PF, KERSTEN JR:Decreased tetrahydrobiopterin and disrupted association of Hsp90 with eNOS by hyperglycemia impair myocardial ischemic preconditioning. Am J Physiol 301: H2130-H2139, 2011.
46. YADAV HN, SINGH M, SHARMA PL: Involvement of GSK-3β in attenuation of the cardioprotective effect of ischemic preconditioning in diabetic rat heart. Mol Cell Biochem 343: 75-81, 2010.
47. YIN X, ZHENG Y, ZHAI X, ZHAO X, CAI L: Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury. Exp Diabetes Res 2012: Article ID 198048-2012, .
48. YU XY, GENG YJ, LIANG JL, LIN SG, ZHANG S, LI Y: High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor. Exp Cell Res 316: 2903-2909, 2010.
49. ZHAO M, XIA L, CHEN GQ: Protein kinase Cδ in apoptosis: a brief overview. Arch Immunol Ther Exp (Warsz) 60: 361-372, 2012.